Trial Profile

Phase I trial of a biogenic amine reuptake inhibitor under development for CNS disorders

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 07 Sep 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs CNS disorders therapeutic Curia/Bristol Myers Squibb (Primary)
Indications Solid tumours
Focus Therapeutic Use

Most Recent Events

30 May 2011 Company MR states that phase II development is underway. Assumed that this trial has now been completed.
25 May 2011 Status changed from recruiting to completed, according to information in an AMRI media release.
11 Jun 2009 New trial record.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com